Cargando…
Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
The length of anticoagulation for thrombotic events related to COVID‐19 is unknown. We present a patient with COVID‐19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoagulation...
Autores principales: | Garg, Rimmy, Sachdeva, Amitoj, Del Cid Fratti, Juan, Mortoti, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207223/ https://www.ncbi.nlm.nih.gov/pubmed/35765294 http://dx.doi.org/10.1002/ccr3.5950 |
Ejemplares similares
-
The role of rivaroxaban in left ventricular thrombi
por: Abdelnaby, Mahmoud, et al.
Publicado: (2019) -
Ball-Shaped Thrombi in the Left Ventricular Apex
por: Kim, Hyoung-Duk, et al.
Publicado: (2011) -
Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
por: Shokr, Mohamed, et al.
Publicado: (2018) -
Thrombophilia, Left Ventricular Dysfunction and Intracardiac Thrombi in Children
por: Abu-Kishk, Ibrahim, et al.
Publicado: (2011) -
Left Ventricular Noncompaction with Multiple Thrombi in Apical Aneurysm
por: Yakabe, Daisuke, et al.
Publicado: (2019)